Samraat S. Raha - 11 Jun 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: President and CEO, Director
Issuer ticker: MYGN
Reported as of: 11 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jun 2026, 18:06:04 UTC
Prior SEC filing: 16 Mar 2026
Source filing: View source filing
Reporting owner signature: By: Justin Hunter For: Samraat S. Raha

Key filing fact

Samraat S. Raha filed Form 4 for MYRIAD GENETICS INC (MYGN) on 12 Jun 2026.

Key facts

This page summarizes Samraat S. Raha's Form 4 filing for MYRIAD GENETICS INC (MYGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2026, 18:06.

Change

Previous filing in this sequence was filed on 16 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001738340 Primary reporting owner

Raha Samraat S.

Relationship: President and CEO, Director
Address: 322 NORTH 2200 WEST, SALT LAKE CITY
Signature: By: Justin Hunter For: Samraat S. Raha
Signature date: 12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN transaction

Common Stock

Award

Transaction value
Shares: +3,542
Change %: +0.33%
Price: $3.94^*
Shares after: 1,068,083
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).